Dr Sarah Wordsworth
|Tel||+44 (0)1865 289 268|
BSc MSc PhD
Associate Professor and University Research Lecturer
Sarah Wordsworth joined the Health Economics Research Centre in January 2003 and has developed a research programme within HERC on the economics of genetic and genomic technologies. Of particular interest are the economics of translating genomic high-throughput technologies from research into clinical practice, in both cancer and cardiovascular disease. In October 2006, Sarah took up a post-doctoral fellowship from the National Institute for Health Research. This fellowship involved methodological and applied research on the economic evaluation of novel genomic technologies in the NHS. Sarah's other interests include costing methodology and trial based evaluations in the areas of eye disease, blood transfusion, cardiac surgery and surgery for obesity. Prior to this appointment, Sarah worked in the Health Economics Research Unit at the University of Aberdeen from 1995-2002, after completing her MSc in Health Economics in 1995 at the University of York.
What Are the Real Procedural Costs of Bariatric Surgery? A Systematic Literature Review of Published Cost Analyses.
Doble B. et al, (2017), Obes Surg, 27, 2179 - 2192
Erratum to: What Are the Real Procedural Costs of Bariatric Surgery? A Systematic Literature Review of Published Cost Analyses.
Doble B. et al, (2017), Obes Surg, 27
Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis.
Buchanan J. et al, (2017), Pharmacoeconomics
Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its Characteristics.
Morrell L. et al, (2017), Pharmacoeconomics
Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.
Hamblin A. et al, (2017), PLoS Med, 14